Quantcast
Home / DC News / SCOTUS to decide on failure to warn drug suit preemption

SCOTUS to decide on failure to warn drug suit preemption

The U.S. Supreme Court has agreed to decide whether state law tort suits against generic drug manufacturers alleging failure to warn and misrepresentation are preempted by federal law.